Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
WST
NYSE·Healthcare·Medical - Instruments & Supplies·Mkt cap $25.8B
$365.74
▲ +0.20%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$206.80 - $367.57
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Up 65.0% over the trailing year
Total returns
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
Bear Case
2 risks
Growth
Stable outlook
Increasing global biologics market
Value
High premium - requires strong execution
Momentum
Hot
+43.3% over 3m
Quality
Stable
Exceptional business - top-tier fundamentals
Dividend
Token
0.24% yield
Smart-money signal
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Apr 22, 2026
APR 23, 2026
Reported EPS of $2.13 vs $1.68 consensus (+26.8% surprise). Revenue of $844.9M vs $780.3M expected (+8.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+26.8%
Next: Apr 22, 2026
Revenue trend · last 8Q
—
—
+2%
+0%
+9%
+8%
+8%
+21%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$702.0M
$746.9M
$748.5M
$698.2M
$766.2M
$804.3M
$805.0M
$844.9M
Margins · last 8Q
Gross
35.1%
Operating
21.0%
Profit
16.4%
Wall Street consensus
Live ratings and price targets aggregated across covering analysts.
Buy
75%
Hold
25%
Sell
0%
Median Price Target
$312.50
▼ -14.6% vs $365.74
Latest: KeyBanc · Jul 2, 2026
2 analysts covering